drugset / Trial / NCT01080807

Efficacy and Tolerability of Armodafinil in Adults With Excessive Sleepiness Associated With Shift Work Disorder

NCT01080807

Phase 4 Completed 385 enrolled Cephalon
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The primary objective of the study is to determine whether armodafinil treatment is more effective than placebo treatment in patients with excessive sleepiness associated with shift work disorder (SWD) by measuring improved clinical condition late in the shift, including the commute home.

Timeline

Start
2010-03
Primary completion
2010-10
Completion
2010-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Armodafinil Small molecule 150 mg

Indications